Article: Threshold Pharmaceuticals Initiates Phase 1 Clinical Trial Evaluating TH-302 in Patients With Solid Tumors.

Article: Boston Life Sciences' Antigen-Targeting Protein Suppresses ...
Business Wire;  January 11, 2000 ;     700+ words ... ... approximately 70% of all solid tumors, including those of the ... represents the largest segment of solid tumors, and which also have been ... factor for the treatment of solid tumors; AF-1 and Inosine, nerve ... regulatory submissions, th

Article: Current Status of Therapy of Solid Tumors
The Journal of Nuclear Medicine;  January 1, 2005 ;     700+ words ... ... Success in the radioimmunotherapy of solid tumors has lagged because of the immunogenicity ... for successful radioimmunotherapy of solid tumors. This review will describe seminal ... understanding of radioimmunotherapy in solid tumors. Finally, the authors' views of the ...

Article: Clinical Data Reported on Vidaza in Hematologic Malignancies and ...
PR Newswire;  June 2, 2007 ;     700+ words ... ... in Combination with Valproic Acid for Solid Tumors Presented at the American Society of ... hematologic malignancies and advanced solid tumors. These data were presented at the 43rd ... treatment of hematologic malignancies and solid tumors and are the subject of poster and oral ...

Article: Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in ...
PR Newswire;  May 1, 2008 ;     700+ words ... ... of proteasome activity, in relapsed solid tumors. A Phase 1b dose-escalation trial of carfilzomib in patients with advanced solid tumors has recently been completed. The Phase ... patients with recurrent or advanced solid tumors. Subjects will be enrolled and stratified ...

Article: Bone marrow metastasis of solid tumors: ...
Turkish Journal of Cancer;  January 1, 2007 ;     700+ words ... ... adult patients with BM metastases of solid tumors diagnosed by bone marrow (BM) aspiration ... lt;0.0001). BM involvement by solid tumors carries a poor prognosis, especially ... lymphoid hematological malignancies, solid tumors may also spread to the BM via the hematogenous ...

Article: ARIAD Presents Preclinical Data on Its Kinase Inhibitor, AP24534, ...
Business Wire;  October 24, 2008 ;     700+ words ... ... highlight the potential for AP24534 to treat solid tumors based on its unique profile. Our dose ... into clinical development for selected solid tumors as well." Data from the in vivo studies ... characteristics of AP24534 activity in solid tumors: * Potent inhibition of new blood ...

Article: The Revised Metabolic Oncolytic Regimen for Effecting Lysis in ...
Townsend Letter for Doctors and Patients;  August 1, 2001 ;     700+ words ... ... of the oncolytic approach to treating solid tumors was first published during December ... on an approach to achieving lysis in solid tumors pioneered by Clarence Cone, Jr ... it is hypoxic clusters within certain solid tumors - and not the entire tumor - which synthesizes ...